全文获取类型
收费全文 | 12705篇 |
免费 | 1205篇 |
国内免费 | 203篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 153篇 |
妇产科学 | 66篇 |
基础医学 | 879篇 |
口腔科学 | 190篇 |
临床医学 | 912篇 |
内科学 | 2580篇 |
皮肤病学 | 145篇 |
神经病学 | 1057篇 |
特种医学 | 204篇 |
外国民族医学 | 1篇 |
外科学 | 313篇 |
综合类 | 797篇 |
现状与发展 | 2篇 |
预防医学 | 2068篇 |
眼科学 | 63篇 |
药学 | 3724篇 |
1篇 | |
中国医学 | 415篇 |
肿瘤学 | 513篇 |
出版年
2023年 | 260篇 |
2022年 | 224篇 |
2021年 | 516篇 |
2020年 | 362篇 |
2019年 | 403篇 |
2018年 | 549篇 |
2017年 | 569篇 |
2016年 | 529篇 |
2015年 | 467篇 |
2014年 | 661篇 |
2013年 | 1846篇 |
2012年 | 613篇 |
2011年 | 694篇 |
2010年 | 533篇 |
2009年 | 507篇 |
2008年 | 543篇 |
2007年 | 511篇 |
2006年 | 443篇 |
2005年 | 392篇 |
2004年 | 370篇 |
2003年 | 342篇 |
2002年 | 265篇 |
2001年 | 247篇 |
2000年 | 215篇 |
1999年 | 152篇 |
1998年 | 147篇 |
1997年 | 128篇 |
1996年 | 125篇 |
1995年 | 136篇 |
1994年 | 116篇 |
1993年 | 104篇 |
1992年 | 87篇 |
1991年 | 106篇 |
1990年 | 82篇 |
1989年 | 61篇 |
1988年 | 78篇 |
1987年 | 68篇 |
1986年 | 60篇 |
1985年 | 108篇 |
1984年 | 81篇 |
1983年 | 60篇 |
1982年 | 58篇 |
1981年 | 61篇 |
1980年 | 49篇 |
1979年 | 45篇 |
1978年 | 29篇 |
1977年 | 30篇 |
1976年 | 18篇 |
1975年 | 17篇 |
1973年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kari Hemminki Kristina Sundquist Jan Sundquist Asta Försti Vaclav Liska Akseli Hemminki Xinjun Li 《International journal of cancer. Journal international du cancer》2023,152(6):1107-1114
Many environmental risk factors for hepatobiliary cancers are known but whether they are associated with specific cancer types is unclear. We present here a novel approach of assessing standardized incidence ratios (SIRs) of previously diagnosed comorbidities for hepatocellular carcinoma (HCC), gallbladder cancer (GBC), cholangiocarcinoma (CCA) and ampullary cancer. The 13 comorbidities included alcohol and nonalcohol related liver disease, chronic obstructive pulmonary disease, gallstone disease, viral and other kinds of hepatitis, infection of bile ducts, hepatic and other autoimmune diseases, obesity and diabetes. Patients were identified from the Swedish Inpatient Register from 1987 to 2018, and their cancers were followed from 1997 onwards. SIRs for HCC were 80 to 100 in men and women diagnosed with hepatitis C virus and they were also >10 in patients diagnosed with hepatitis B virus, other kind of hepatitis, hepatic autoimmune disease and nonalcohol related liver disease. Many of these risks, as well as alcohol related liver disease, were either specific to HCC or were shared with intrahepatic CCA. For GBC, CCA and ampullary cancer infection of bile ducts was the main risk factor. Gallstone disease, nonhepatic autoimmune diseases and diabetes were associated with all hepatobiliary cancers. The limitations of the study include inability to cover some rare risk factors and limited follow-up time. Many of the considered comorbidities are characterized by chronic inflammation and/or overt immune disturbance in autoimmune diseases. The results suggest that local chronic inflammation and a related immune disturbance is the carcinogenic trigger for all these cancers. 相似文献
2.
3.
4.
5.
6.
7.
Cheryl L. Rock PhD RD Cynthia A. Thomson PhD RD Kristen R. Sullivan MS MPH Carol L. Howe MD MLS Lawrence H. Kushi ScD Bette J. Caan DrPH Marian L. Neuhouser PhD RD Elisa V. Bandera MD PhD Ying Wang PhD Kimberly Robien PhD RD Karen M. Basen-Engquist PhD MPH Justin C. Brown PhD Kerry S. Courneya PhD Tracy E. Crane PhD RDN David O. Garcia PhD FACSM Barbara L. Grant MS RDN CSO FAND Kathryn K. Hamilton MA RDN CSO CDN FAND Sheri J. Hartman PhD Stacey A. Kenfield ScD Maria Elena Martinez PhD Jeffrey A. Meyerhardt MD MPH Larissa Nekhlyudov MD MPH Linda Overholser MD Alpa V. Patel PhD Bernardine M. Pinto PhD Mary E. Platek PhD RD CDN Erika Rees-Punia PhD MPH Colleen K. Spees PhD MEd RD LD FAND Susan M. Gapstur PhD Marjorie L. McCullough ScD RD 《CA: a cancer journal for clinicians》2022,72(3):230-262
The overall 5-year relative survival rate for all cancers combined is now 68%, and there are over 16.9 million survivors in the United States. Evidence from laboratory and observational studies suggests that factors such as diet, physical activity, and obesity may affect risk for recurrence and overall survival after a cancer diagnosis. The purpose of this American Cancer Society guideline is to provide evidence-based, cancer-specific recommendations for anthropometric parameters, physical activity, diet, and alcohol intake for reducing recurrence and cancer-specific and overall mortality. The audiences for this guideline are health care providers caring for cancer survivors as well as cancer survivors and their families. The guideline is intended to serve as a resource for informing American Cancer Society programs, health policy, and the media. Sources of evidence that form the basis of this guideline are systematic literature reviews, meta-analyses, pooled analyses of cohort studies, and large randomized clinical trials published since 2012. Recommendations for nutrition and physical activity during cancer treatment, informed by current practice, large cancer care organizations, and reviews of other expert bodies, are also presented. To provide additional context for the guidelines, the authors also include information on the relationship between health-related behaviors and comorbidities, long-term sequelae and patient-reported outcomes, and health disparities, with attention to enabling survivors' ability to adhere to recommendations. Approaches to meet survivors' needs are addressed as well as clinical care coordination and resources for nutrition and physical activity counseling after a cancer diagnosis. 相似文献
8.
9.
10.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383